{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:53:50Z","timestamp":1758819230182,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1D1A1B03935584"],"award-info":[{"award-number":["2016R1D1A1B03935584"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2017R1A2B4007704"],"award-info":[{"award-number":["2017R1A2B4007704"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00428-018-2390-5","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T05:44:35Z","timestamp":1529473475000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal\/ovarian carcinoma in patients with a history of breast carcinoma"],"prefix":"10.1007","volume":"473","author":[{"given":"Kiyong","family":"Na","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Youn","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gun Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja Seung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-7822","authenticated-orcid":false,"given":"Hyun-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"2390_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4143\/crt.2014.143","volume":"47","author":"YA Kim","year":"2015","unstructured":"Kim YA, Oh IH, Yoon SJ, Kim HJ, Seo HY, Kim EJ, Lee YH, Jung JH (2015) The economic burden of breast cancer in Korea from 2007-2010. Cancer Res Treat 47:583\u2013590. \n                    https:\/\/doi.org\/10.4143\/crt.2014.143","journal-title":"Cancer Res Treat"},{"key":"2390_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-013-2561-7","volume":"139","author":"N Bouganim","year":"2013","unstructured":"Bouganim N, Tsvetkova E, Clemons M, Amir E (2013) Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research. Breast Cancer Res Treat 139:603\u2013606. \n                    https:\/\/doi.org\/10.1007\/s10549-013-2561-7","journal-title":"Breast Cancer Res Treat"},{"key":"2390_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s40064-015-1449-x","volume":"4","author":"S Bertozzi","year":"2015","unstructured":"Bertozzi S, Londero AP, Cedolini C, Uzzau A, Seriau L, Bernardi S, Bacchetti S, Pasqual EM, Risaliti A (2015) Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. Springerplus 4:688. \n                    https:\/\/doi.org\/10.1186\/s40064-015-1449-x","journal-title":"Springerplus"},{"key":"2390_CR4","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1007\/s10620-008-0529-y","volume":"53","author":"SM Sheen-Chen","year":"2008","unstructured":"Sheen-Chen SM, Liu YW, Sun CK, Lin SE, Eng HL, Huang WT, Ko SF (2008) Abdominal carcinomatosis attributed to metastatic breast carcinoma. Dig Dis Sci 53:3043\u20133045. \n                    https:\/\/doi.org\/10.1007\/s10620-008-0529-y","journal-title":"Dig Dis Sci"},{"key":"2390_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4174\/astr.2017.93.6.287","volume":"93","author":"HK Jung","year":"2017","unstructured":"Jung HK, Park S, Kim NW, Lee JE, Kim Z, Han SW, Hur SM, Kim SY, Lim CW, Lee MH, Lee J (2017) Development of second primary cancer in Korean breast cancer survivors. Ann Surg Treat Res 93:287\u2013292. \n                    https:\/\/doi.org\/10.4174\/astr.2017.93.6.287","journal-title":"Ann Surg Treat Res"},{"key":"2390_CR6","first-page":"449","volume":"84","author":"JP Curtin","year":"1994","unstructured":"Curtin JP, Barakat RR, Hoskins WJ (1994) Ovarian disease in women with breast cancer. Obstet Gynecol 84:449\u2013452","journal-title":"Obstet Gynecol"},{"key":"2390_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ygyno.2005.05.013","volume":"99","author":"R Garg","year":"2005","unstructured":"Garg R, Zahurak ML, Trimble EL, Armstrong DK, Bristow RE (2005) Abdominal carcinomatosis in women with a history of breast cancer. Gynecol Oncol 99:65\u201370. \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2005.05.013","journal-title":"Gynecol Oncol"},{"key":"2390_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00125480-200607000-00004","volume":"13","author":"TC Pereira","year":"2006","unstructured":"Pereira TC, Saad RS, Liu Y, Silverman JF (2006) The diagnosis of malignancy in effusion cytology: a pattern recognition approach. Adv Anat Pathol 13:174\u2013184","journal-title":"Adv Anat Pathol"},{"key":"2390_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1097-0339(199802)18:2<141::AID-DC11>3.0.CO;2-L","volume":"18","author":"CW Bedrossian","year":"1998","unstructured":"Bedrossian CW (1998) Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology. Diagn Cytopathol 18:141\u2013149","journal-title":"Diagn Cytopathol"},{"key":"2390_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/dc.2840080219","volume":"8","author":"KV Nance","year":"1992","unstructured":"Nance KV, Silverman JF (1992) The utility of ancillary techniques in effusion cytology. Diagn Cytopathol 8:185\u2013189","journal-title":"Diagn Cytopathol"},{"key":"2390_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cncy.21393","volume":"122","author":"PW Shield","year":"2014","unstructured":"Shield PW, Papadimos DJ, Walsh MD (2014) GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Cancer Cytopathol 122:307\u2013312. \n                    https:\/\/doi.org\/10.1002\/cncy.21393","journal-title":"Cancer Cytopathol"},{"key":"2390_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1756-8722-6-60","volume":"6","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Li J, Yuan Z, Yuan B, Zhang T, Cragun JM, Kong B, Zheng W (2013) PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy. J Hematol Oncol 6:60. \n                    https:\/\/doi.org\/10.1186\/1756-8722-6-60","journal-title":"J Hematol Oncol"},{"key":"2390_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1309\/QLV6-HH0H-UCTF-WEF6","volume":"117","author":"BH Lee","year":"2002","unstructured":"Lee BH, Hecht JL, Pinkus JL, Pinkus GS (2002) WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am J Clin Pathol 117:745\u2013750. \n                    https:\/\/doi.org\/10.1309\/QLV6-HH0H-UCTF-WEF6","journal-title":"Am J Clin Pathol"},{"key":"2390_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000356426","volume":"58","author":"L Waters","year":"2014","unstructured":"Waters L, Crumley S, Truong L, Mody D, Coffey D (2014) PAX2 and PAX8: useful markers for metastatic effusions. Acta Cytol 58:60\u201366. \n                    https:\/\/doi.org\/10.1159\/000356426","journal-title":"Acta Cytol"},{"key":"2390_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00428-017-2186-z","volume":"471","author":"K Na","year":"2017","unstructured":"Na K, Kim HS (2017) Clinicopathological characteristics of fallopian tube metastases from primary endometrial, cervical, and nongynecological malignancies: a single institutional experience. Virchows Arch 471:363\u2013373. \n                    https:\/\/doi.org\/10.1007\/s00428-017-2186-z","journal-title":"Virchows Arch"},{"key":"2390_CR16","doi-asserted-by":"publisher","unstructured":"Na K, Kim HS (2017) Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body. Am J Surg Pathol:1. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000991","DOI":"10.1097\/PAS.0000000000000991"},{"key":"2390_CR17","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.21873\/anticanres.12128","volume":"37","author":"K Na","year":"2017","unstructured":"Na K, Sung JY, Kim HS (2017) TP53 mutation status of tubo-ovarian and peritoneal high-grade serous carcinoma with a wild-type p53 immunostaining pattern. Anticancer Res 37:6697\u20136703. \n                    https:\/\/doi.org\/10.21873\/anticanres.12128","journal-title":"Anticancer Res"},{"key":"2390_CR18","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784\u20132795. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.25.6529","journal-title":"J Clin Oncol"},{"key":"2390_CR19","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997\u20134013. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.50.9984","journal-title":"J Clin Oncol"},{"key":"2390_CR20","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.ejca.2009.04.027","volume":"45","author":"M Tuthill","year":"2009","unstructured":"Tuthill M, Pell R, Guiliani R, Lim A, Gudi M, Contractor KB, Lewis JS, Coombes RC, Stebbing J (2009) Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis. Eur J Cancer 45:2146\u20132149. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2009.04.027","journal-title":"Eur J Cancer"},{"key":"2390_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jmedgenet-2013-101607","volume":"50","author":"SL Ingham","year":"2013","unstructured":"Ingham SL, Warwick J, Buchan I, Sahin S, O'Hara C, Moran A, Howell A, Evans DG (2013) Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2. J Med Genet 50:368\u2013372. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2013-101607","journal-title":"J Med Genet"},{"key":"2390_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/IGC.0b013e3181a12e8b","volume":"19","author":"I Gulhan","year":"2009","unstructured":"Gulhan I, Eser S, Yakut C, Bige O, Ilhan E, Yildirim Y, Saygili U (2009) Second primary gynecologic cancers after breast cancer in Turkish women. Int J Gynecol Cancer 19:648\u2013650. \n                    https:\/\/doi.org\/10.1111\/IGC.0b013e3181a12e8b","journal-title":"Int J Gynecol Cancer"},{"key":"2390_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-006-9446-y","volume":"105","author":"A Trentham-Dietz","year":"2007","unstructured":"Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105:195\u2013207. \n                    https:\/\/doi.org\/10.1007\/s10549-006-9446-y","journal-title":"Breast Cancer Res Treat"},{"key":"2390_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-015-3658-y","volume":"155","author":"KL Kehl","year":"2016","unstructured":"Kehl KL, Shen C, Litton JK, Arun B, Giordano SH (2016) Rates of BRCA1\/2 mutation testing among young survivors of breast cancer. Breast Cancer Res Treat 155:165\u2013173. \n                    https:\/\/doi.org\/10.1007\/s10549-015-3658-y","journal-title":"Breast Cancer Res Treat"},{"key":"2390_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jnci\/dju380","volume":"107","author":"R Manchanda","year":"2015","unstructured":"Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I (2015) Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing. J Natl Cancer Inst 107:380. \n                    https:\/\/doi.org\/10.1093\/jnci\/dju380","journal-title":"J Natl Cancer Inst"},{"key":"2390_CR26","first-page":"2339","volume":"26","author":"A Tserkezoglou","year":"2006","unstructured":"Tserkezoglou A, Kontou S, Hadjieleftheriou G, Apostolikas N, Vassilomanolakis M, Sikiotis K, Salamalekis E, Tseke P, Magiakos G (2006) Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results. Anticancer Res 26:2339\u20132344","journal-title":"Anticancer Res"},{"key":"2390_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar P, Aggarwal R (2016) An overview of triple-negative breast cancer. Arch Gynecol Obstet 293:247\u2013269. \n                    https:\/\/doi.org\/10.1007\/s00404-015-3859-y","journal-title":"Arch Gynecol Obstet"},{"issue":"Suppl 1","key":"2390_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","volume":"16","author":"CA Hudis","year":"2011","unstructured":"Hudis CA, Gianni L (2011) Triple-negative breast cancer: an unmet medical need. Oncologist 16(Suppl 1):1\u201311. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2011-S1-01","journal-title":"Oncologist"},{"key":"2390_CR29","doi-asserted-by":"publisher","first-page":"e38361","DOI":"10.1371\/journal.pone.0038361","volume":"7","author":"P Meyer","year":"2012","unstructured":"Meyer P, Landgraf K, Hogel B, Eiermann W, Ataseven B (2012) BRCA2 mutations and triple-negative breast cancer. PLoS One 7:e38361. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0038361","journal-title":"PLoS One"},{"key":"2390_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000455999","volume":"12","author":"E Hahnen","year":"2017","unstructured":"Hahnen E, Hauke J, Engel C, Neidhardt G, Rhiem K, Schmutzler RK (2017) Germline mutations in triple-negative breast cancer. Breast Care (Basel) 12:15\u201319. \n                    https:\/\/doi.org\/10.1159\/000455999","journal-title":"Breast Care (Basel)"},{"key":"2390_CR31","first-page":"1270","volume":"34","author":"M Zhang","year":"2013","unstructured":"Zhang M, Sun J (2013) Bone metastasis from ovarian cancer. Clinical analysis of 26 cases. Saudi Med J 34:1270\u20131273","journal-title":"Saudi Med J"},{"key":"2390_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0090-8258(03)00400-1","volume":"90","author":"G Cormio","year":"2003","unstructured":"Cormio G, Capotorto M, Di Vagno G, Cazzolla A, Carriero C, Selvaggi L (2003) Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature. Gynecol Oncol 90:682\u2013685","journal-title":"Gynecol Oncol"},{"key":"2390_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3760\/cma.j.issn.0253-3766.2013.03.010","volume":"35","author":"Q Li","year":"2013","unstructured":"Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q (2013) Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases. Zhonghua Zhong Liu Za Zhi 35:207\u2013211. \n                    https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2013.03.010","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2390_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0339(199607)15:1<1::AID-DC2>3.0.CO;2-N","volume":"15","author":"S Raptis","year":"1996","unstructured":"Raptis S, Kanbour AI, Dusenbery D, Kanbour-Shakir A (1996) Fine-needle aspiration cytology of metastatic ovarian carcinoma to the breast. Diagn Cytopathol 15:1\u20136. \n                    https:\/\/doi.org\/10.1002\/(SICI)1097-0339(199607)15:1<1::AID-DC2>3.0.CO;2-N","journal-title":"Diagn Cytopathol"},{"key":"2390_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/dc.10176","volume":"27","author":"H Bayramoglu","year":"2002","unstructured":"Bayramoglu H, Zekioglu O, Erhan Y, Ciris M, Ozdemir N (2002) Fine-needle aspiration biopsy of invasive micropapillary carcinoma of the breast: a report of five cases. Diagn Cytopathol 27:214\u2013217. \n                    https:\/\/doi.org\/10.1002\/dc.10176","journal-title":"Diagn Cytopathol"},{"key":"2390_CR36","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1159\/000327111","volume":"46","author":"S Jaffer","year":"2002","unstructured":"Jaffer S, Reid-Nicholson M, Bleiweiss IJ (2002) Infiltrating micropapillary carcinoma of the breast. Cytologic Findings Acta Cytol 46:1081\u20131087. \n                    https:\/\/doi.org\/10.1159\/000327111","journal-title":"Cytologic Findings Acta Cytol"},{"key":"2390_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/his.12877","volume":"68","author":"AM Gown","year":"2016","unstructured":"Gown AM, Fulton RS, Kandalaft PL (2016) Markers of metastatic carcinoma of breast origin. Histopathology 68:86\u201395. \n                    https:\/\/doi.org\/10.1111\/his.12877","journal-title":"Histopathology"},{"key":"2390_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/dc.23448","volume":"44","author":"UN Sheikh","year":"2016","unstructured":"Sheikh UN, Cohen C, Siddiqui MT (2016) Utility of folate receptor alpha immunohistochemistry in cytology specimens of metastatic breast carcinoma, metastatic serous carcinoma of Mullerian origin, and primary lung adenocarcinoma. Diagn Cytopathol 44:369\u2013376. \n                    https:\/\/doi.org\/10.1002\/dc.23448","journal-title":"Diagn Cytopathol"},{"key":"2390_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.clbc.2015.03.010","volume":"15","author":"S Rossi","year":"2015","unstructured":"Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R, D'Argento E, Cassano A, Schinzari G, Barone C (2015) Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease. Clin Breast Cancer 15:307\u2013312. \n                    https:\/\/doi.org\/10.1016\/j.clbc.2015.03.010","journal-title":"Clin Breast Cancer"},{"key":"2390_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12282-015-0615-x","volume":"23","author":"Y Nakayama","year":"2016","unstructured":"Nakayama Y, Nakagomi H, Omori M, Inoue M, Takahashi K, Maruyama M, Takano A, Furuya K, Amemiya K, Ishii E, Oyama T (2016) Benefits of using the cell block method to determine the discordance of the HR\/HER2 expression in patients with metastatic breast cancer. Breast Cancer 23:633\u2013639. \n                    https:\/\/doi.org\/10.1007\/s12282-015-0615-x","journal-title":"Breast Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-018-2390-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T14:43:48Z","timestamp":1569249828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-018-2390-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2390"],"URL":"https:\/\/doi.org\/10.1007\/s00428-018-2390-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Review Board at Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea (4-2017-1247).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}